Cytoskeleton Associated Protein 2 (CKAP2) (C-Term) Peptide
Quick Overview for Cytoskeleton Associated Protein 2 (CKAP2) (C-Term) Peptide (ABIN8098478)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- CKAP2 Peptide - C-terminal region
-
Sequence
- GKAIVDSRSA QPKETSEERK ARLSEWKAGK GRVLKRPPNS VVTQHEPAGQ
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-CKAP2 Antibody (ARP61929_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- CKAP2 (Cytoskeleton Associated Protein 2 (CKAP2))
-
Background
-
Background Information: CKAP2 is a cytoskeleton-associated protein involved in mitotic progression.
Alternative Symbols: DKFZp686L1238, FLJ10749, LB1, TMAP, se20-10
-
Molecular Weight
- 77kDa
-
Gene ID
- 26586
-
NCBI Accession
- NP_001091995
-
UniProt
- Q8WWK9
Target
-